the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

NASA, MOSTI strengthen ties to advance space collaboration

PUTRAJAYA: Malaysia and NASA have taken a significant step toward enhancing their collaboration in space technology, aiming to position Malaysia as a key player in the global space arena.

The need for deeper collaboration was highlighted during a meeting between Dr Katherine Calvin, chief scientist and senior climate advisor to NASA Administrator Bill Nelson and Minister of Science, Technology, and Innovation Chang Lih Kang, in Putrajaya today.

In a statement today, the Ministry of Science, Technology, and Innovation (MOSTI) said that the meeting highlighted the significance of fostering international partnerships, particularly in the fields of science, technology, innovation, and economic development, all geared toward advancing Malaysia’s leadership in the space arena.

“The discussions between MOSTI and NASA focused on building robust partnerships, to accelerate the growth of Malaysia’s space technology industry,” the statement read.

MOSTI highlighted that this collaboration aligns strategically with the National Space Policy Action Plan 2030, also known as Malaysia Space Exploration 2030, which aims to enhance scientific research and development while solidifying Malaysia’s position in the competitive global space economy.

“Additionally, it supports Thrust 6: Global Prominence of the National Policy on Science, Technology, and Innovation (NPSTI) 2021-2030, which aims to strengthen both domestic and international collaboration in these critical areas,” it said.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings